up-RBD conformation and lead to a non-RBM-binding 
monoclonal antibody escape. Nat Commun 2022, 13:1-12. 
43. Walls AC, et al.: Structure, function, and antigenicity of the 
SARS-CoV-2 spike glycoprotein. Cell 2020, 181:e286. 
44. McCallum M, et al.: N-terminal domain antigenic mapping 
reveals a site of vulnerability for SARS-CoV-2. Cell 2021, 
184:e2316. 
45. Suryadevara N, et al.: Neutralizing and protective human 
monoclonal antibodies recognizing the N-terminal domain of 
the SARS-CoV-2 spike protein. Cell 2021, 184:e2315. 
8 Virus structure and expression  
www.sciencedirect.com Current Opinion in Virology 2023, 61:101332